Loading clinical trials...
Loading clinical trials...
Dual therapy for Helicobacter pylori refers to a treatment regimen that combines two agents: a potent acid suppressor (such as a proton pump inhibitor \[PPI\] or a potassium-competitive acid blocker \...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Soonchunhyang University Hospital
NCT07344506 · H. Pylori Gastrointestinal Disease, H.Pylori Infection, and more
NCT07284355 · H.Pylori Infection
NCT06431737 · H.Pylori Infection
NCT02332213 · Colorectal Cancer, Colorectal Adenoma, and more
Digestive Disease Center, Soonchunhyang University Hospital
Seoul
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions